Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)

NCT: NCT05398341 · ACTIVE_NOT_RECRUITING

NCT IDNCT05398341
StatusACTIVE_NOT_RECRUITING
Start Date2023-02-28
Completion2027-01-30
SponsorMiach Orthopaedics (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the Bridge Registry is to assess real-world performance of the FDA approved BEAR Implant.

Frequently Asked Questions

What is A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)?

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®) is a clinical trial registered under NCT05398341. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05398341?

The current status of NCT05398341 (A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)) is: ACTIVE_NOT_RECRUITING.

When did A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®) start?

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®) started on 2023-02-28.

Related Devices

K243578BEAR® (Bridge-Enhanced ACL Restoration) ImplantMiach Orthopaedics, Inc. K251214BEAR® (Bridge-Enhanced ACL Restoration) ImplantMiach Orthopaedics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑